Hosted on MSN47m
Alzheimer's disease could be stopped in its tracks by new drug with potential to 'prevent progression'
This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...
McKnight's Long-Term Care News16h
Promising new Alzheimer’s drug candidate developed by international research team
A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
Marketing Week11d
‘Evolution, not revolution’: Alzheimer’s Society on ‘stripping back’ to make a bigger impact
The Alzheimer’s Society is on a mission to tell the “hundreds of thousands” of real stories of living with dementia after ...
New study is a promising ‘first’ in Alzheimer’s drug development
Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...
Hosted on MSN13h
Breakthrough Alzheimer's Drug Targets Key 'Hotspots' to Suppress Toxic Tangles
Brains affected by Alzheimer's disease are characterized by damaging clumps and tangles that interfere with neurons – but a ...
newmarkettoday3d
Alzheimer Society hosts nature walks to encourage connections
Social isolation is a top dementia risk factor and can exacerbate existing dementia symptoms and caregiver stress, Alzheimer ...
Breakthrough Alzheimer’s drug successfully blocks both major disease ‘hotspots’ at once for the first time
RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...
Neuroscience News3d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
The Football Association11d
The FA and Alzheimer’s Society reach £1 million partnership milestone
Alzheimer’s Society CEO, Kate Lee, said: “What an achievement for our partnership with the FA! The power of the partnership ...
Business Wire5d
BPGbio to Present Novel Drug Target for Huntington’s Disease and AI Discovered Biomarkers for Alzheimer’s Disease at Society for Neuroscience 2024
BPGbio to present novel Huntington's Disease and Alzheimer's Disease research at the Society for Neuroscience 2024 annual meeting.
Promising ‘first’ in Alzheimer’s drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...